Showing results (31-40 of 105) with videos related to
Sort By:
Pageof 11
Journal of Human Hypertension|August 15, 1998
Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressuresA R Lorimer, D Lyons, G Fowler, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Benzothiadazine diuretics and death from myocardial infarction in hypertensionJ V Jones, F G Dunn, R Fife, et al.Circulation|March 1, 1993
A predictive method for estimating the late angiographic results of coronary intervention despite incomplete ascertainmentR E Kuntz, K M Keaney, C Senerchia, et al.Nephron|January 1, 1987
Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?G R Bailie, R Morton, L Ganguli, et al.Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.Postgraduate Medical Journal|January 1, 1975
The prevalence of hyperlipoproteinaemia in vascular diseaseT D Lawrie, A R Lorimer, D Ballantyne, et al.Artery|January 1, 1980
Combined drug therapy for familial hypercholesterolemiaC J Packard, J M Stewart, H G Morgan, et al.Postgraduate Medical Journal|January 1, 1981
Non-invasive cardiovascular assessment of indapamide in patients with essential hypertensionF G Dunn, W S Hillis, A Tweddel, et al.Atherosclerosis|September 1, 1982
Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsJ M Stewart, C J Packard, A R Lorimer, et al.British Journal of Pharmacology|May 1, 1974
The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in manW S Hillis, I Hutton, T D Lawrie, et al.Pageof 11